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SCHOOL OF PHARMACY 
OFFICE OF THE DEAN 
University, MS 38677 
Phone: (662) 915-7265 Fax: (662) 915-5704 
 
TO:  All School of Pharmacy Personnel 
 
FROM: Charles D. Hufford, Associate Dean for Research and Graduate Programs 
 
DATE:  October 10, 2005 
 
SUBJECT: Research News (#3) 
 
 
The following GRANTS/CONTRACTS have recently been awarded: 
1. Dr. Mitchell Avery (P.I. – Medicinal Chemistry) – Development and Testing of New Antimalarial 
Drugs (Department of Health and Human Services/Centers for Disease Control and 
Prevention/National Center for Infectious Diseases), $3,000,000.00 – August 1, 2005-July 31, 2006.  
2. Dr. Mitchell Avery (P.I. – Medicinal Chemistry) – Development and Testing of New Medicines for 
Treatment of Emerging Infectious Diseases – Year 3 (Department of Health and Human 
Services/Centers for Disease Control and Prevention), $1,500,000.00 – September 15, 2005-
September 14, 2006. 
3. Dr. Joseph Byrd (P.I. – Pharmacy Practice) – Agreement for Clinical Liaison (University of 
Mississippi Medical Center Department of Medicine), $57,840.00 – April 1, 2005-March 31, 2006. 
4. Dr. Joseph Byrd (P.I. – Pharmacy Practice) – Contract for Residency Training Program Support 
(University of Mississippi Medical Center), $25,000.00 – July 1, 2005-June 30, 2006. 
5. Dr. Joseph Byrd (P.I. – Pharmacy Practice) – UM School of Pharmacy and Baptist Memorial 
Hospital – North Mississippi Agreement (Baptist Memorial Hospital – North Mississippi), 
$56,250.00 – July 19, 2005-July 18, 2006.  
6. Dr. Joseph Byrd (P.I. – Pharmacy Practice) – Delta Diabetes Project (University of Mississippi 
Medical Center), $38,973.00 – August 1, 2005-July 31, 2006. 
7. Dr. Alice Clark (P.I. – School of Pharmacy/Office of Research and Sponsored Programs) and Dr. 
Ameeta Agarwal (Co-P.I. – NCNPR) – New Drugs for Opportunistic Infections (National Institutes 
of Health/National Institutes of Allergy and Infectious Diseases), $314,593.00 – July 1, 2005-June 30, 
2006. 
8. Dr. John Cleary (P.I. – Pharmacy Practice) – Amphotericin B High Purity for the Treatment of 
Opportunistic Infections in Patients with AIDS (STTR & Cumberland Pharmaceuticals/National 
Institutes of Health), $60,137.00 – July 13, 2005-March 31, 2006. 
9. Dr. John Cleary (P.I. – Pharmacy Practice) – Pharmaceutical Company Support (Clinical 
Microbiology Institute), $2,400.00 – July 20, 2005-July 19, 2006. 
10. Dr. Victor Dostrow (P.I. – Pharmacy Practice) and Dr. Brian Crabtree (Co-P.I. – Pharmacy 




Comorbid Epilepsy and Psychiatric Illness (Abbott Laboratories), $62,450.00 – September 9, 2005-
November 8, 2006. 
11. Dr. Melissa Jacob (P.I. – NCNPR) – Anti-Fungal Testing of New Drugs (Florida A & M/National 
Institutes of Health), $20,470.00 – June 1, 2005-May 31, 2006. 
12. Dr. Ikhlas Khan (P.I. – NCNPR) – Optimizing Therapeutic Ratios of Herbs: Gingko as a Model 
(Harvard University/National Institutes of Health), $87,917.11 – July 1, 2005-September 30, 2005. 
13. Dr. Ikhlas Khan (P.I. – NCNPR) – Mechanisms of Gingko biloba Neuroprotection (The University 
of Southern Mississippi/National Institutes of Health), $38,000.00 – September 15, 2004-May 31, 
2006. 
14. Dr. Ikhlas Khan (P.I. – NCNPR) – Optimization of Large-Scale Production of Value-Added 
Standardized Medicinal Plant Extracts (Civil Engineering Research Foundation), $7,000.00 – August 
25, 2005-June 30, 2006. 
15. Dr. Thomas Lombardo (P.I. – Psychology/Office of Research and Sponsored Programs) and Dr. 
John Bentley (Co-P.I. – Pharmacy Administration) – “ACT Now” Tobacco Intervention Program 
(University of Mississippi Medical Center/Partnership for a Healthy Mississippi), $101,666.25 – June 
1, 2005-May 31, 2006. 
16. Dr. Soumyajit Majumdar (P.I. – Pharmaceutics) – Berberine Project (Next Pharmaceuticals, Inc.), 
$12,500.00 – October 7, 2005-December 6, 2005. 
17. Dr. Rae Matsumoto (P.I. – Pharmacology) – Sigma Ligands for the Treatment of Cocaine Overdose 
(National Institute on Drug Abuse), $250,418.00 – August 1, 2005-July 31, 2006. 
18. Dr. David Pasco (P.I. – NCNPR), Dr. Nirmal Pugh (Co-P.I. – NCNPR), Dr. Ikhlas Khan (Co-P.I. 
– NCNPR) and Dr. Rita Moraes (Co-P.I. – NCNPR) – New Immuno-Active Compounds for 
Optimizing Echinacea (National Institutes of Health/National Center for Complementary & 
Alternative Medicine), $284,203.00 – September 15, 2005-July 31, 2006. 
19. Dr. Marc Slattery (P.I. – Pharmacognosy) – The National Institute for Undersea Science and 
Technology – 2005 Research – Phase II (U.S. Department of Commerce, National Oceanic and 
Atmospheric Administration), $1,499,792.00 – July 1, 2005-September 30, 2006. 
20. Dr. Larry Walker (P.I. – NCNPR), Dr. Dhammika Nanayakkara (Co-P.I. – NCNPR) and Dr. 
Babu Tekwani (Co-P.I. – NCNPR) – NPC 1161B – Year 2 (Medicines for Malaria Venture), 
$619,800.00 – July 1, 2005-December 31, 2005. 
21. Dr. Larry Walker (P.I. – NCNPR) and Dr. Ikhlas Khan (Co-P.I. – NCNPR) – Botanical Dietary 
Supplements: Science-Base for Authentication and Analysis (Food and Drug Administration), 
$855,881.00 – September 30, 2005-September 29, 2006. 
22. Dr. Larry Walker (P.I. – NCNPR) and Dr. Ikhlas Khan (Co-P.I. – NCNPR) – Botanical Dietary 
Supplements: Science-Base for Authentication and Analysis – Supplement (Food and Drug 
Administration), $493,453.00 – September 30, 2005-September 29, 2006. 
23. Dr. Barbara Wells (P.I. – RIPS/School of Pharmacy) and Dr. Charles Hufford (Co-P.I. – 
RIPS/School of Pharmacy) – National Center for Natural Products Research – Phase II Auditorium 
(Department of Health and Human Services/Health Resources and Services Administration), 
$2,553,369.00 – September 1, 2005-August 31, 2006. 
24. Dr. John Williamson (P.I. – Medicinal Chemistry), Dr. Mitchell Avery (Co-P.I. – Medicinal 
Chemistry), Dr. Ronald Borne (Co-P.I. – Medicinal Chemistry), Dr. Christopher McCurdy (Co-
P.I. – Medicinal Chemistry) and Dr. John Rimoldi (Co-P.I. – Medicinal Chemistry) – IGERT-
Entrepreneurship at the Interface of Polymer Science and Medicinal Chemistry (The University of 
Southern Mississippi/National Science Foundation), $322,120.00 – October 1, 2005-September 30, 
2006. 
25. Dr. John Williamson (P.I. – Medicinal Chemistry) and Dr. Mary Haasch (Co-P.I. – RIPS/ECHR) – 
INBRE Mississippi Functional Genomics Network (MFGN) (The University of Southern 
Mississippi/National Institutes of Health), $100,800.00 – July 1, 2005-March 1, 2006. 
26. Dr. Jordan Zjawiony (P.I. – Pharmacognosy) – Semisynthesis of Salvinorin A Derivatives and 
Analogs for k-Opioid Receptor and Related Studies (Case Western Reserve University/National 






The following PUBLICATIONS have appeared: 
1. A.A. Ahmed, M.M. Bishr, M.A. El-Shanawany, E.Z. Attia, Samir Ross and P.W. Pare – “Rare 
trisubstituted sesquiterpenes daucanes from the wild Daucus carota”, Phytochemistry, 66, 1680-1684, 
2005. 
2. J.L. Arbiser, Xing-Cong Li, Chowdhury Hossain, Dale Nagle, D.M. Smith, P. Miller, B. 
Govindarajan, J. DiCarlo, K.R. Landis-Piwowar and Q.P. Dou – “Naturally Occurring Proteasome 
Inhibitors from Mate Tea (Ilex paraguayensis) Serve as Models for Topical Proteasome Inhibitors”, 
The Society for Investigative Dermatology, 207-212, August 2005. 
3. Premalatha Balachandran, Feng Wei, R.C. Lin, Ikhlas Khan and David Pasco – “Structure 
activity relationships of aristolochic acid analogues: Toxicity in cultured renal epithelial cells”, 
Kidney International, 67, 1797-1805, 2005. 
4. J.T. DiPiro, R.L. Talbert, G.C. Yee, G.R. Matzke, Barbara Wells, and L.M. Posey (editors) – 
Pharmacotherapy: A Pathophysiologic Approach, 6th Edition, McGraw-Hill, 2005. 
5. Daneel Ferreira, Jannie P.J. Marais and Desmond Slade – “Heterogeneity of the interflavanyl 
bond in proanthocyanidins from natural sources lacking C-4 (C-ring) deoxy flavonoid nucleophiles”, 
Phytochemistry, 66, 2216-2237, 2005. 
6. Daneel Ferreira, G.G. Gross, H. Kolodziej and T. Yoshida – “Tannins and related polyphenols: 
Fascinating natural products with diverse implications for biological systems, ecology, industrial 
applications and health protection”, Phytochemistry, 66, 1969-1971, 2005. 
7. N. Fukamiya, K.H. Lee, Ilias Muhammad, C. Murakami, M. Okano, I. Harvey and J. Pelletier – 
“Structure-activity relationships of quassinoids for eukaryotic protein synthesis”, Cancer Letters, 220, 
37-48, 2005. 
8. A.M. Galal, Samir Ross, Melissa Jacob and Mahmoud ElSohly – “Antifungal Activity of 
Artemisinin Derivatives”, Journal of Natural Products, 68, 1274-1276, 2005. 
9. W.J. Geldenhuys, P.R. Lockman, Ashok Philip, J.H. McAfee, Bryan Miller, Christopher 
McCurdy and D.D. Allen – “Inhibition of choline uptake by N-cyclohexylcholine, a high affinity 
ligand for the choline transporter at the blood-brain barrier”, Journal of Drug Targeting, 13, 259-266, 
2005. 
10. Chowdhury Hossain, Young-Pil Kim, Scott Baerson, L. Zhang, R.K. Bruick, K.A. Mohammed, 
Ameeta Agarwal, Dale Nagle and Yu-Dong Zhou – “Saururus cernuus ligands – Potent small 
molecule inhibitors of hypoxis-inducible factor-1”, Biochemical and Biophysical Research 
Communications, 333, 1026-1033, 2005. 
11. Xiuhong Ji, Ikhlas Khan, J.A. Mosjidis, H. Wang and P. Livant – “Variability for the presence of 
pyrrolizidine alkaloids in Crotolaria juncea L.”, Pharmazie, 60, 620-622, 2005. 
12. Vaishali Joshi, P.V. Srinivas and Ikhlas Khan – “Rapid and Easy Identification of Illicium verum 
Hook.f. and Its Adulterant Illicium anisatum Linn. By Fluorescent Microscopy and Gas 
Chromatography”, Journal of AOAC International, 88, 703-705, 2005. 
13. Vaishali Joshi and Ikhlas Khan – “Macroscopic and Microscopic Authentication of Chinese and 
North American Species of Ephedra”, Journal of AOAC International, 88, 707-713, 2005. 
14. J.T. Kando, Barbara Wells and P. E. Hayes – “Depressive Disorders”, Pharmacotherapy: A 
Pathophysiologic Approach, 6th Edition, 1235-1255, 2005. 
15. C.K. Kirkwood, E.H. Makela and Barbara Wells – “Anxiety Disorders II: Posttraumatic Stress 
Disorder and Obsessive Compulsive Disorder”, Pharmacotherapy: A Pathophysiologic Approach, 6th 
Edition, 1307-1319, 2005. 
16. Jannie P.J. Marais, Daneel Ferreira and Desmond Slade – “Stereoselective synthesis of 
monomeric flavonoids”, Phytochemistry, 66, 2145-2176, 2005. 
17. S.M. Mustafa, S.A. Bavadekar, G. Ma, B. Moore, Dennis Feller and D.D. Miller – “Synthesis and 
Biological Studies of Yohimbine Derivatives on Human Alpha2C-Adrenergic Receptors”, Bioorganic 
and Medicinal Chemistry Letters, 15, 2758-2760, 2005. 
 
4
18. J.H. Poupaert, P. Carato and Christopher McCurdy – “A Simple and Effective Method for the 
Thionation of Amides to Thioamides usingA12O3-supported P4S10”, Letters in Organic Chemistry, 
2, 330-333, 2005. 
19. S. Prodduturi, R.V. Manek, W.M. Kolling, Steven Stodghill and Michael Repka – “Solid-State 
Stability and Characterization of Hot-Melt Extruded Poly(Ethylene Oxide) Films”, Journal of 
Pharmaceutical Science, 94, 2232-2245, 2005. 
20. John Rimoldi, Satish Puppali, E. Isin, P. Bissel, A. Khalil and N. Castagnoli – “A novel and 
selective monoamine oxidase B substrate”, Bioorganic & Medicinal Chemistry, 13, 5808-5813, 2005. 
21. Samir Ross, M.A. Al-Azeib, K.S. Krishnaveni, F.R. Fronczek and Charles Burandt – “Alkamides 
from the Leaves of Zanthoxylum syncarpum”, Journal of Natural Products, 68, 1297-1299, 2005. 
22. Desmond Slade, Daneel Ferreira and Jannie P.J. Marais – “Circular dichroism, a powerful tool for 
the assessment of absolute configuration of flavonoids”, Phytochemistry, 66, 2177-2215, 2005. 
23. A. Slominski, I. Semak, Jordan Zjawiony, J. Wortsman, W. Li, A. Szczesniewski and R.C. Tuckey 
– “The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism”, The 
FEBS Journal, 272, 4080-4090, 2005. 
24. A. Slominski, I. Semak, Jordan Zjawiony, J. Wortsman, M.N. Gandy, J. Li, B. Zbytek, W. Li and 
R.C. Tuckey – “Enzymatic Metabolism of Ergosterol by Cytochrome P450scc to Biologically Active 
17 ,24-Dihydroxyergosterol”, Chemistry and Biology, 12, 931-939, 2005. 
25. Barbara Wells, J.T. DiPiro, T.L. Schwinghammer and C.W. Hamilton (editors) – Pharmacotherapy 
Handbook, 6th Edition, McGraw-Hill, 2005. 
26. Barbara Wells – “Residency Training: It’s Time to Get Serious!”, President’s Column, American 
College of Clinical Pharmacy (ACCP) Report, 23(11), 3-4, 2004. 
27. Barbara Wells – “The Greatest Injustice of All”, President’s Column, ACCP Report, 24(1), 3-4, 
2005. 
28. Barbara Wells – “Investing in the Future of Clinical Pharmacy: Bringing Students into the Fold”, 
President’s Column, ACCP Report, 24(5), 2005. 
29. Barbara Wells – “Leadership Development: A Commitment to Patients and the Profession”, 
President’s Column, ACCP Report, 24 (7), 4-5, 2005. 
30. F. Yan, P.D. Mosier, R.B. Westkaemper, J. Stewart, Jordan Zjawiony, T.A. Vortherms, D.J. 
Sheffler and B.L. Roth – “Identification of the Molecular Mechanisms by Which the Diterpenoid 
Salvinorin A Binds to –Opioid Receptors”, Biochemistry, 44, 8643-8651, 2005. 
31. Yu-Dong Zhou, Yong-Pil Kim, K.A. Mohammed, D.K. Jones, Ilias Muhammad, D.C. Dunbar and 
Dale Nagle – “Terpenoid Tetrahydroisoquinoline Alkaloids Emetine, Klugine, and Isocephaeline 
Inhibit the Activation of Hypoxia-Inducible Factor-1 in Breast Tumor Cells”, Journal of Natural 
Products, 68, 947-950, 2005. 
 
 
TECHNOLOGY TRANSFER transactions: 
(In the interest of protecting confidential information, the names and titles associated with School of 
Pharmacy invention disclosures and patent applications will no longer be published until after a patent 
has issued.) 
Invention Disclosures Filed in 2005:   7 
Patent Applications Pending:  33 
Recent Patents Granted:    0 
 
 
Please continue to send me important research and graduate information so that I might share it with your 
faculty colleagues.  THIS INFORMATION IS NOW BEING POSTED ON THE SCHOOL OF 
PHARMACY WEB PAGE (www.pharmacy.olemiss.edu)!  Thank you. 
 
 
cc: Dean Barbara G. Wells 
 Ms. Dabney Weems  
 Ms. Euphiazene Gray, Office of Research 
